Medicover Genetics CY successfully renews CAP accreditation

Medicover Genetics has successfully renewed its accreditation from the College of American Pathologists (CAP) following a comprehensive on-site inspection of our Cyprus laboratories. This renewal reaffirms our continuous commitment to diagnostic quality, regulatory compliance, and patient safety.

Commenting on the achievement, Dr Marios Ioannides, Managing Director of Medicover Genetics Cyprus, noted, “Maintaining CAP accreditation is a significant milestone for our laboratory. It attests to the scientific discipline, quality assurance practices, and technical excellence that guide our work every day. This recognition reinforces our commitment to delivering reliable, high-quality diagnostic services to patients and clinical partners.”

The CAP accreditation process is one of the most rigorous evaluations in laboratory medicine. Inspectors assess laboratory records, quality control systems, staff qualifications, equipment performance, facilities, safety practices, and overall management covering the previous two years. With only a select number of laboratories in Europe achieving CAP accreditation, this recognition places Medicover Genetics among the region’s leading diagnostic providers committed to meeting internationally validated standards.